# The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study

> **NCT07089173** · NA · RECRUITING · sponsor: **Peking University Shenzhen Hospital** · enrollment: 99 (estimated)

## Conditions studied

- Hemodynamics

## Interventions

- **DRUG:** Intravenous normal saline (NS 0.9)
- **DRUG:** intravenous sufentanil
- **DRUG:** Intravenous lidocaine

## Key facts

- **NCT ID:** NCT07089173
- **Lead sponsor:** Peking University Shenzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089173, "The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07089173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*